Codexis (CDXS) Receivables - Other (2010 - 2026)
Codexis (CDXS) recorded quarterly Receivables - Other of $852000.0 in Q1 2026, down 51.06% quarter-over-quarter from $1.7 million in Q4 2025, and down 77.86% on a YoY basis from $3.8 million in Q1 2025.
Codexis (CDXS) Receivables - Other (2010 - 2026) Analysis & Trends
Codexis' Receivables - Other history runs 15 years deep, the most recent figure standing at $852000.0 for Q1 2026.
- In Q1 2026, Receivables - Other fell 77.86% year-over-year to $852000.0; the TTM figure through Mar 2026 stood at $852000.0 (down 77.86% YoY), while the FY2025 annual figure was $1.7 million, down 36.71% from the prior year.
- Receivables - Other was $852000.0 for Q1 2026 at Codexis, down from $1.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $10.7 million in Q2 2023 to a low of $852000.0 in Q1 2026.
- Historically, Receivables - Other has averaged $5.7 million across 5 years, with a median of $5.5 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Receivables - Other surged 41.16% in 2023, then tumbled 77.86% in 2026.
- A 5-year view of Receivables - Other shows it stood at $7.0 million in 2022, then soared by 41.16% to $9.9 million in 2023, then sank by 72.22% to $2.8 million in 2024, then tumbled by 36.71% to $1.7 million in 2025, then plunged by 51.06% to $852000.0 in 2026.
- The last three Receivables - Other figures came in at $852000.0 (Q1 2026), $1.7 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 852,000.00 |
| Mar 31, 2026 | 852,000.00 |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Dec 31, 2024 | 2.75 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Sep 30, 2024 | 4.79 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 9.90 Mn |
| Dec 31, 2023 | 9.90 Mn |